- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.12.25 | Cordlife faces $5.45m in claims over 109 damaged cord blood units | 2 | Singapore Business Review | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| CORDLIFE GROUP Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-INDEPENDENT NON-EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RECEIPT OF NOTICE OF REGULATORY ACTION | 2 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 4 | SGX Company Announcements | ||
| 27.11.25 | Health ministry suspends Cordlife's blood banking license | 3 | Singapore Business Review | ||
| 27.11.25 | CORDLIFE GROUP LIMITED: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: REPL::FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CESSATION OF EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 27.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::SUBMISSION OF WRITTEN REPRESENTATIONS TO MOH | 2 | SGX Company Announcements | ||
| 21.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CLARIFICATION TO CERTAIN MEDIA REPORTS | 1 | SGX Company Announcements | ||
| 13.10.25 | Cordlife granted extension to appeal license suspension | 2 | Singapore Business Review | ||
| 13.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF TIME GRANTED BY MOH TO PROVIDE WRITTEN REPRESENTATIONS | 1 | SGX Company Announcements | ||
| 07.10.25 | Cordlife assures continuity of operations amidst possible licence suspension | 7 | Singapore Business Review | ||
| 06.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON GOING CONCERN ASSESSMENT | 1 | SGX Company Announcements | ||
| 02.10.25 | Cordlife to assess 'going concern' viability amidst potential suspension | 5 | Singapore Business Review | ||
| 01.10.25 | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 1 | SGX Company Announcements |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| Q&M DENTAL | 0,200 | -1,96 % | Q & M DENTAL GROUP (SINGAPORE) LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF CHANGES IN INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - DR. NG CHIN SIAU | ||
| SDI LIMITED | - | - | SDI LIMITED: Trading Update December 2025 | ||
| SIEMENS HEALTHINEERS | 46,310 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | 0,00 % | Abend-Update: Fresenius Medical Care-Aktie stürzt ab - was ist jetzt noch zu retten? | ||
| FRESENIUS | 48,970 | 0,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,90 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,28 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| HEARTFLOW | 32,580 | +4,52 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | 0,00 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| BETA BIONICS | 31,490 | +0,35 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,300 | +0,14 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 89,44 | -5,78 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
CORDLIFE GROUP LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORDLIFE GROUP LIMITED finden Sie auf Wallstreet Online.